activistletters
Mason Capital Challenges Proxy Advisors Over JBS S.A. (JBS) NYSE Listing, Cites Conflicts and $16B Value at Risk
Summary
On May 15, 2025, Mason Capital, a 2.4% minority shareholder in JBS S.A., sent a letter to
activistletters
HG Vora Presses for Change at PENN (PENN), Nominates Three Directors to Challenge Failed Strategy and Excessive CEO Pay
Summary
HG Vora, a 4.8% shareholder in PENN Entertainment, criticized the company’s long-term underperformance, failed digital strategy, and
activistletters
Servotronics (SVT) Faces Beaver Hollow Wellness’ Push for Director Change After Cash Collapse and Governance Failures
Summary
Beaver Hollow Wellness (May 13, 2025) launched its S.A.V.E. Servotronics Plan, urging board change after years
activistletters
Dynavax (DVAX): Deep Track Capital (14.8% Holder) Pushes Board Slate, Urges Focus on Heplisav and Capital Returns
Summary
Deep Track Capital, owning ~14.8% of Dynavax, filed a proxy statement urging shareholders to support its board nominees
activistletters
Harley-Davidson (HOG) Faces Intensified H Partners Campaign as Proxy Advisors and Dealers Back Withhold Effort
Summary
The H Partners letter (May 9, 2025) urges Harley-Davidson shareholders to withhold votes from CEO Jochen Zeitz, Thomas Linebarger,
activistletters
Keros Therapeutics (KROS) Faces ADAR1’s Push for Restructuring, $500M Capital Return, and Board Refresh
Summary
ADAR1 Capital (May 2025) blasted Keros Therapeutics for mismanaging its pipeline, wasting cash, and eroding shareholder value. It cites
activistletters
Harley-Davidson (HOG): H Partners Wins Proxy Advisor, Dealer Support to Oust CEO Zeitz and Two Long-Tenured Directors
Summary
H Partners urged shareholders to vote “WITHHOLD” on the re-election of CEO/Chairman Jochen Zeitz, Presiding Director Thomas Linebarger,
activistletters
ADAR1 Capital Presses Keros (KROS) to Halt Value-Destructive Programs, Focus on Takeda Partnership, and Add Shareholder Representation
Summary
ADAR1 Capital, owning 13.3% of Keros Therapeutics, criticized the company’s strategy, citing poor clinical results for two
activistletters
BML Capital Presses AN2 (ANTX) to Return Cash to Shareholders, Warns Against Risky Preclinical Pivot
Summary
BML Capital, owning 19.1% of AN2 Therapeutics, urged the Board to pursue a sale or orderly wind-down of
activistletters
Findell Capital Presses for Change at Oportun (OPRT), Citing Governance Failures, Cost Bloat, and Value-Destructive Acquisitions
Summary
Findell Capital, Oportun’s largest shareholder with a 9.5% stake, is seeking to replace entrenched directors and improve
activistletters
Al Hartman Challenges Silver Star (SLVS) Over Distressed Sales, Cites $7.4M Value Loss and Puts Directors on Notice
Summary
Al Hartman criticized Silver Star’s recent sale of its Gulf Interstate property, claiming it was sold for just
activistletters
Findell Capital (9.5% Stake) Presses Oportun Financial (NASDAQ: OPRT) on Governance Failures, Nominates Warren Wilcox to Board
Summary
Findell Capital, the largest shareholder of Oportun Financial Corporation (roughly 9.5% stake), sharply criticizes the board’s governance
activistletters
Elliott Investment Management Challenges Phillips 66 (PSX) Board, Seeks Four Director Seats and Stronger Governance
Summary
Elliott Investment Management, a top-five shareholder in Phillips 66, called on shareholders to vote the Gold Card in support
activistletters
Servotronics (SVT): Save Servotronics Group Urges Shareholders to Elect New Board Amid Governance Failures and Strategic Alternatives Concerns
Summary
Paul L. Snyder III, leading a shareholder campaign, urged Servotronics shareholders to vote the WHITE proxy card in favor
activistletters
Impactive Capital Presses WEX (WEX) for Board Refresh, Governance Reform, and Accountability Following 250pt Lag vs Peer Corpay
Summary
Impactive Capital, a 7% shareholder in WEX Inc., announced its intention to vote AGAINST three incumbent directors—CEO/Chair
activistletters
Phillips 66 (PSX) Faces Elliott’s Push for Board Overhaul Amid Governance Failures and Refining Underperformance
Summary
The Elliott addendum (May 2, 2025) intensifies its proxy fight with Phillips 66. Elliott rebuts management’s claims about
activistletters
National Health Investors (NHI) Faces Land & Buildings’ Push for Board Change Amid NHC Lease Concerns and Governance Failures
Summary
The Land & Buildings (L&B) presentation dated May 2, 2025, continues its activist campaign against National Health
activistletters
Lyft (LYFT) Faces Engine Capital’s Push for Board Refresh Amid Value Destruction and Shareholder Dilution
Summary
The Engine Capital presentation (April 29, 2025) argues that Lyft has destroyed shareholder value, underperformed Uber and the market,
